Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Somer G. Anderson is CPA, doctor of ...
Vor Biopharma Inc. (VOR) stock jumped to a high of $12 yesterday, gaining >20%, but as I discovered to my detriment recently, all is not exactly what it seems at the company. In this post I revisit a ...
Optical remote sensing technologies provide the ability to monitor short- and long-term changes in coral reefs, deep-sea fisheries, and off-shore oilfields, and to supply real-time information about ...
The VOR X RWY 10 at TNCM is incorrectly read by the FMC and incorrectly displayed - NAV mode cannot be used to fly approach. Programme the TNCM VOR X approach to TNCM through PJM. When comparing ...
Vor Biopharma's estimated fair value is US$15.10 based on 2 Stage Free Cash Flow to Equity Vor Biopharma is estimated to be 49% undervalued based on current share price of US$7.68 Our fair value ...
Vor Biopharma Inc. (NASDAQ:VOR) on Tuesday priced an underwritten public offering of 10 million shares at $10.00 per share. The gross proceeds from the offering are expected to be $100 million. In ...
Hosted on MSN
Trying a VOR Instrument Approach!
I love being a licensed private pilot. As you may have seen from other videos, I am starting my instrument rating training. I really believe that I will be a much safer pilot when I get my IFR or ...
FRIDAY: A customer flew in from Lubbock for a couple of VOR approaches, then back in his Piper Cherokee 180. Mark Parish flew locally in his Cessna 182 Skylane. Med-Trans flew over to Covenant Health ...
Vor Biopharma, a cancer cell therapy developer that laid off nearly all of its employees in a wind down of operations last month, has reemerged with new management, an in-licensed lead drug candidate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback